BiOptic Inc. (6850.TWO)

TWD 44.0

(1.38%)

Market Cap (In TWD)

1.32 Billion

Revenue (In TWD)

228.26 Million

Net Income (In TWD)

37.74 Million

Avg. Volume

39.23 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
42.0-63.0
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006850001
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
-
Employee Count
-
Website
https://www.bioptic.com.tw
Ipo Date
2021-11-10
Details
BiOptic Inc., a biotechnology instrumentation company, develops scientific products for research and clinical applications. It offers instruments, such as bio-fragment analyzers and PCR thermocyclers; consumables, including DNA, RNA, and protein cartridges, as well as quantification kits; premix and polymerase PCR reagents; and veterinary, human, and food related testing kits. BiOptic Inc.was founded in 1993 and is headquartered in New Taipei City, Taiwan.